$13.09
-0.11 (-0.83%)
Performance
1D
—
1W
—
1M
—
3M
-81.85%
6M
-69.29%
1Y
-59.16%
YTD
-81.84%
Open$13.41
Previous Close$13.20
Day High$13.41
Day Low$12.77
52W High$73.06
52W Low$13.06
Volume—
Avg Volume6.38M
Market Cap2.25B
P/E Ratio—
EPS$-4.17
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$72.38
Below
SMA 200
$51.57
Below
RSI (14)
65.9
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.86M | 14.11M | 2.36B |
| Net Income | -439,382,306 | -375,504,772 | -651,372,475 |
| Profit Margin | -2,957.7% | -2,809.8% | -27.6% |
| EBITDA | -513,142,555 | -462,905,163 | -865,943,607 |
| Free Cash Flow | — | — | -400,975,764 |
| Rev Growth | +5.3% | +5.3% | +6.9% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |